Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Hear from an expert on what are the main challenges in treating Patients with CRS with Nasal Polyps?

Hear from an expert on what are the main challenges in treating Patients with CRS with Nasal Polyps?

Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Expert group consensus from the Arabian Peninsula on the diagnosis of LOPD

Expert group consensus from the Arabian Peninsula on the diagnosis of LOPD

T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

Diagnostic Algorithm for Gaucher Disease in Pediatric

Diagnostic Algorithm for Gaucher Disease in Pediatric

Diagnostic Algorithm for Gaucher Disease in Adult

Diagnostic Algorithm for Gaucher Disease in Adult

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

The superiority of Biologics over OCS for disease modifying potential which explains the superiority over OCS as anti-inflammatory option for our patients with CRSwNP, when we prescribe the Biologicals, we prescribe them long term for chronic disease where we do believe that we do not only aim to reduce inflammation but also to have some disease modifying effects.

Bone Monitoring Guidelines in Gaucher Disease Video

Bone Monitoring Guidelines in Gaucher Disease Video

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyp mystery

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyp mystery

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia